Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Berkeley and Advanced Medical Solutions raised

Mon, 28th Apr 2025 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

----------

FTSE 100

----------

UBS raises Berkeley Group Holdings to 'buy' (neutral) - price target 4,965 (5,385) pence

----------

Peel Hunt raises Antofagasta to 'add' (hold) - price target 1,860 (1,825) pence

----------

Citigroup cuts HSBC price target to 990 (1,070) pence - 'buy'

----------

Citigroup cuts Standard Chartered price target to 1,115 (1,250) pence - 'neutral'

----------

HSBC cuts AstraZeneca price target to 12,000 (13,720) pence - 'buy'

----------

Deutsche Bank Research raises BAE Systems price target to 1,900 (1,510) pence - 'buy'

----------

Goldman Sachs cuts Centrica price target to 186 (187) pence - 'buy'

----------

Goldman Sachs cuts WPP price target to 649 (655) pence - 'neutral'

----------

Barclays cuts WPP price target to 700 (780) pence - 'equal weight'

----------

UBS cuts WPP price target to 520 (580) pence - 'sell'

----------

UBS cuts Diageo price target to 2,650 (2,920) pence - 'buy'

----------

Jefferies cuts Diageo price target to 2,500 (2,800) pence - 'buy'

----------

JPMorgan raises Fresnillo price target to 1,450 (1,000) pence - 'overweight'

----------

Jefferies raises Coca-Cola HBC price target to 4,400 (3,750) pence - 'buy'

----------

Jefferies cuts St James's Place price target to 1,160 (1,266) pence - 'buy'

----------

Jefferies cuts Unilever price target to 3,600 (3,700) pence - 'underperform'

----------

FTSE 250

----------

Exane BNP cuts Inchcape to 'neutral' (outperform) - price target 725 (975) pence

----------

Deutsche Bank Research starts Sirius Real Estate with 'buy' - price target 110 pence

----------

RBC starts Qinetiq with 'sector perform' - price target 450 pence

----------

RBC starts Chemring with 'outperform' - price target 500 pence

----------

UBS cuts Victrex price target to 780 (1000) pence - 'sell'

----------

JPMorgan cuts Man Group to 'neutral' (overweight) - price target 167 (242) pence

----------

Morgan Stanley cuts Burberry price target to 825 (1,125) pence - 'equal-weight'

----------

RBC cuts Asos price target to 400 (450) pence - 'sector perform'

----------

RBC cuts PageGroup price target to 385 (445) pence - 'outperform'

----------

RBC cuts Hays price target to 100 (105) pence - 'outperform'

----------

JPMorgan raises Hochschild Mining target to 430 (300) pence - 'overweight'

----------

SMALL CAP

----------

Stifel raises Advanced Medical Solutions to 'buy' (hold) - price target 245 pence

----------

RBC starts Cohort with 'outperform' - price target 1,570 pence

----------

RBC cuts Ceres Power price target to 90 (110) pence - 'sector perform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Berkeley Group Antofagasta HSBC Holdings Standard Chartered Astrazeneca BAE Systems WPP Diageo Fresnillo Coca-Cola HBC St James's Place Unilever Inchcape Chemring Qinetiq Man Sirius Real Estate Victrex Burberry ASOS PageGroup Hays Hochschild Advanced Medical Solutions Group Cohort Ceres Power

Shares in this article

Related News

LONDON MARKET CLOSE: Miners lift FTSE 100 while oil price heads lower
14 hours ago

LONDON MARKET CLOSE: Miners lift FTSE 100 while oil price heads lower

(Alliance News) - The FTSE 100 made steady progress on Tuesday, with events in the Middle East continuing to largely dictate the market mood.

Market News Elementis + 12 more shares
AstraZeneca breast cancer drug camizestrant shows "sustained" benefit
18 hours ago

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit

(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant.